tiprankstipranks

Alimera Sciences downgraded to Neutral from Buy at Alliance Global Partners

Alliance Global Partners downgraded Alimera Sciences (ALIM) to Neutral from Buy after the company agreed to be bought by ANI Pharmaceuticals (ANIP) for $381M, or $5.50 per share, in cash upfront plus a CVR.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue